Clinical Trials Logo

Caffeine clinical trials

View clinical trials related to Caffeine.

Filter by:

NCT ID: NCT05811923 Completed - Metabolic Syndrome Clinical Trials

Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine

PX
Start date: December 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the acute impact of ingesting individual and combined dosages of caffeine and paraxanthine in comparison to placebo on changes in resting metabolic rate, perceived levels of affect, and markers of lipolysis.

NCT ID: NCT05715073 Completed - Cognitive Change Clinical Trials

Improving Cognition With Neurodegradation Countermeasure

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized, placebo-controlled, three-condition, double-blind, within-participants crossover clinical trial is to compare caffeine, TeaCrine plus caffeine, and a placebo condition in ROTC or tactical personnel. The main question it aims to answer is the effect of the condition on measures of cognitive performance, cardio-autonomic, and hemodynamic responses after a physically demanding protocol. The physiological function will be derived from metrics of heart rate variability, whilst cogntive performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory. Participants will report to the lab 4 times, once for familiarization of cognitive measures and then 3 times for their experimental visits. Participants will consume their randomized condition an hour prior to the fatiguing interval exercise protocol. Following they will complete a series of cognitive tasks.

NCT ID: NCT05560620 Completed - Cognitive Change Clinical Trials

Sleep Deprivation Study

Start date: June 3, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the measures of brain function, both neurophysiological (event-related potentials (ERPs) and functional (cognitive assessments), in response to sleep deprivation.

NCT ID: NCT05559372 Completed - Mood Clinical Trials

Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

Energy drinks are widely promoted to increase energy, enhance mental alertness, and improve physical performance. ccording to the National Center for Complementary and Integrative Health (NCCIH) at NIH [1], next to multivitamins, energy drinks are the most popular dietary supplement consumed by American teens and young adults. No two energy drinks are the same, with each using different ingredients. Traditionally, energy drinks contained caffeine, sugar, ginseng and B-vitamins, but newer competitors are bringing different formulations to the market that are also low-calorie/low-sugar and that contain other performance enhancing ingredients, such as beta-alanine and l-citrulline. There are also significant concerns regarding the safety of energy drink consumption. Unfortunately, there are few studies that have (1) examined the effects of energy drink consumption on performance and cardiovascular safety, nor (2) compared these effects among brands with different formulations to examine their safety and efficacy relative to each other and such studies are desperately needed, especially with the growing popularity of energy drinks [3,4].

NCT ID: NCT05521347 Completed - Caffeine Clinical Trials

Caffeine Supplementation Improves the Cognitive Abilities and Shooting Performance of Trained E-sports Players

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Purpose: investigators explored the effect of 3 mg/kg of caffeine supplementation on the cognitive ability and shooting performance of trained e-sports players. Methods: investigators recruited nine e-sports players who had received professional training in e-sports and had won at least eighth place in national-level e-sports shooting competitions. After performing three to five familiarization tests, investigators employed a randomized crossover design to divide participants into a caffeine trial (CAF) and a placebo trial (PL). The CAF group took capsules with 3 mg/kg of caffeine, whereas the PL group took a placebo capsule. After a 1-h rest, the Stroop task, visual search ability test, and the shooting ability test were conducted.

NCT ID: NCT05409339 Completed - Sleep Clinical Trials

Influence of Caffeine Consumption on the Human Circadian System

CICAFF
Start date: May 9, 2016
Phase: N/A
Study type: Interventional

Surveys indicate that 85% of the adult population consume caffeine on a daily basis. Caffeine acts on sleep homeostatic mechanisms by antagonizing the sleep factor adenosine. Whether and how caffeine also impacts on the circadian regulation of sleep and -wakefulness is fairly unexplored. This study quantifies the influence of regular caffeine intake and its cessation on circadian promotion of sleep and wakefulness, on circadian hormonal markers, well-being, neurobehavioral performance and associated cerebral mechanisms. The knowledge is expected to contribute important insights on recent societal changes in sleep-wake behavior (e.g., shorter sleep duration and delayed sleep phase) and the related increase in people suffering from sleep problems.

NCT ID: NCT05393817 Completed - Caffeine Clinical Trials

Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes

Start date: June 8, 2022
Phase:
Study type: Observational

Caffeine citrate, the first-line agent for apnea of prematurity, enhances diaphragmatic activity. EDI values of neurally adjusted ventilatory assist (NAVA) modes can be used to quantify the diaphragmatic activity triggered by electrical impulse from the respiratory center. This study aims to evaluate the EDI changes following caffeine citrate administration and cessation in preterm infants, and whether such changes are affected by different doses used variably in clinical settings.

NCT ID: NCT05330754 Completed - Analgesia Clinical Trials

Caffeine Intake Inrelation to Perioperative Analgesic Consumption

Start date: April 20, 2022
Phase:
Study type: Observational

Caffeine is the most widely consumed psychoactive drug in the world. Natural sources of caffeine include coffee, tea, and chocolate. Synthetic caffeine is also added to products to promote arousal, alertness, energy, and elevated mood. We designed this prospective observational study to determine if caffeine consumption would influence intraoperative analgesic consumption

NCT ID: NCT05323578 Completed - Caffeine Clinical Trials

Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists

Start date: April 18, 2022
Phase:
Study type: Observational

High-caffeine consumption has been increasing in physicians, frequently causing the most common symptoms such as tremor, insomnia, anxiety, and nervousness and rarely leading to serious adverse effects like seizure, acute mania, and stroke due to caffeine overdose. There have been no studies regarding analysis of high-caffeine consumption and its adverse effects among anesthetists.

NCT ID: NCT05230303 Completed - Caffeine Clinical Trials

Caffeine Supplementation, Resistance Training and Blood Antioxidant Status

Start date: January 12, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the effect of acute caffeine intake on resistance training volume and blood antioxidant status, in a randomised, double-blind, placebo-controlled crossover trial.